TERAPIA CELULAR Y MEDICINA REGENERATIVA
NewYork–Presbyterian Hospital
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de NewYork–Presbyterian Hospital (2)
2021
2020
-
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Leukemia, Vol. 34, Núm. 8, pp. 2125-2137